Cancer Letters
Volume 276, Issue 2 , Pages 189-195, 18 April 2009

RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion

  • Ye-Hong Kuang

      Affiliations

    • Department of Dermatology, Xiang Ya Hospital, Central South University, 87 Xiang Ya Road, Changsha, Hunan 410008, China
    • The State Key Laboratory of Medical Genetics, Institute of Medical Genetics, Central South University, Changsha, Hunan 410008, China
  • ,
  • Xiang Chen

      Affiliations

    • Department of Dermatology, Xiang Ya Hospital, Central South University, 87 Xiang Ya Road, Changsha, Hunan 410008, China
    • The State Key Laboratory of Medical Genetics, Institute of Medical Genetics, Central South University, Changsha, Hunan 410008, China
    • Corresponding Author InformationCorresponding author. Address: Department of Dermatology, Xiang Ya Hospital, Central South University, 87 Xiang Ya Road, Changsha, Hunan 410008, China. Tel.: +86 731 432 7377; fax: +86 731 432 8478.
  • ,
  • Juan Su

      Affiliations

    • Department of Dermatology, Xiang Ya Hospital, Central South University, 87 Xiang Ya Road, Changsha, Hunan 410008, China
    • The State Key Laboratory of Medical Genetics, Institute of Medical Genetics, Central South University, Changsha, Hunan 410008, China
  • ,
  • Li-Sha Wu

      Affiliations

    • Department of Dermatology, Xiang Ya Hospital, Central South University, 87 Xiang Ya Road, Changsha, Hunan 410008, China
    • The State Key Laboratory of Medical Genetics, Institute of Medical Genetics, Central South University, Changsha, Hunan 410008, China
  • ,
  • Li-Qiu Liao

      Affiliations

    • Department of General Surgery, Xiang Ya Hospital, Central South University, Hunan, China
  • ,
  • Dai Li

      Affiliations

    • Department of Dermatology, Xiang Ya Hospital, Central South University, 87 Xiang Ya Road, Changsha, Hunan 410008, China
  • ,
  • Zhe-Sheng Chen

      Affiliations

    • Department of Pharmaceutical Sciences, St. John’s University, New York, USA
  • ,
  • Takuro Kanekura

      Affiliations

    • Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

Received 16 September 2008; received in revised form 30 October 2008; accepted 7 November 2008. published online 22 December 2008.

Abstract 

CD147 (basigin, EMMPRIN) is a widely distributed cell surface glycoprotein that belongs to the Ig superfamily. It is highly expressed on the surface of malignant tumor cells to promote their invasiveness and chemo-resistance. The present study aimed to reveal the anti-apoptotic effect of CD147 on the multi-drug resistant (MDR) phenotype of human oral squamous carcinoma cells (SCC) and its possible pathways. Data presented herein showed that MDR derivative SCC KB/V cell line expressed significantly higher CD147 and X-linked inhibitor of apoptosis (XIAP) than its sensitive counterpart KB cells by RT-PCR and Western blot analysis. Down-regulation of CD147 by transfection with CD147 siRNA resulted in decreased XIAP expression. Flow cytometric analysis and electron microscopic observation revealed differential cell apoptotic status related to CD147 expression. Additionally, chemo-sensitivity to 5-fluorouracil of KB/V was increased by CD147 silencing as measured by MTT colorimetric assay. These results suggest that inhibition of CD147 and subsequent XIAP depletion may have an anti-tumor effect through enhancing the susceptibility of cancer cells to apoptosis.

Keywords: Multi-drug resistance, Human oral squamous carcinoma cells, CD147, XIAP, Apoptotic pathways

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(08)00885-9

doi:10.1016/j.canlet.2008.11.010

Cancer Letters
Volume 276, Issue 2 , Pages 189-195, 18 April 2009